Compounds and methods for treatment of viral infections

Psilocybin and O-acetylpsilocin, salts and solid state forms thereof

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

Crystalline forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as inhibitors of phosphatidylinositol-3-kinase

CRYSTALLINE FORMS OF (9R, 135S)-13- {4-[5-CHLORO-2-(4-CHLORO-1H,2,3- TRIAZOL- 1 -YL)PHENYL] -6-OXO- 1,6-DIHYDROPYRIMIDIN- 1-YL}-3-(DIFLUOROMETHYL)-9-METHYL-3,4,7,15- TETRAAZATRICYCLO [ 12.3.1.0 2·6] OCTADECA- 1(18), 2(6), 4, 14, 16-PENTAEN-8-ONE

Polymorphs

Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions

METHODS FOR SYNTHESIS OF CHK1 INHIBITORS

PHARMACEUTICAL COMPOSITION COMPRISING TIZOXANIDE AND PHARMACEUTICAL USE THEREOF

REFINING METHOD

REFINING METHOD

Potassium salt of 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid

Crystalline dimethyl tryptamine analogues

METHOD FOR PRODUCING BENZOPYRANONE COMPOUND AND NOVEL INTERMEDIATE USED THEREIN

SALTS AND SOLID FORMS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE

Boron Containing PDE4 Inhibitors

COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST

Inhibiting agents for bruton's tyrosine kinase

Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide

CRYSTALLINE N-METHYL TRYPTAMINE DERIVATIVES

Crystalline psilacetin derivatives

SALT OF ARYLAMINOPURINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF

MECHANICAL-BOND-PROTECTED STABLE BISRADICALS

Crystalline form of L-glufosinate ammonium salt and process for production thereof

PYRIDONE DERIVATIVE CRYSTAL FORM AND PREPARATION METHOD AND APPLICATION THEREFOR

A2-73 crystalline polymorph compositions of matter and methods of use thereof

NOVEL POLYMORPHIC FORMS OF METOPIMAZINE

CRYSTAL FORM OF DIAZASPIROPYRAN COMPOUND

DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE

SALT FORMS OF BEMPEDOIC ACID AND METHODS FOR USING THE SAME

ALLULOSE IN CRYSTALLINE FORM

Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereof

LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME

Crystalline salts or co-crystals of 2′,6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with p-toluenesulofonic acid as GABAA positive allosteric modulators

RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS

PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE

Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof

CRYSTAL FORM OF FREE ALKALI OF NITROGEN-CONTAINING AROMATIC DERIVATIVES

COCRYSTALS DERIVATIVES OF APIXABAN

Crystal forms of thiazole compound and application thereof

PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM

Processes for producing amide compounds, and their crystalline and salt form

SPIRO RING-CONTAINING QUINAZOLINE COMPOUND

TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

PROCESS FOR THE PREPARATION OF (R)-4-(1-(6-(4-(TRIFLUOROMETHYL)BENZYL)-6-AZASPIRO[2.5]OCTANE-5-CARBOXAMIDO)-CYCLOPROPYL) BENZOIC ACID OR A SALT THEREOF

Crystalline bis-miprocin fumarate

Crystalline 4-hydroxy-N,N-di-n-propyltryptammonium (4-HO-DPT) salts

METHOD AND DEVICE FOR SEPARATION AND PURIFICATION OF GLYCOLIC ACID BY RECTIFICATION-CRYSTALLIZATION COUPLING PROCESS AND USE

Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof

Dosing regimens of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine for treatment of indolent systemic mastocytosis

Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

Crystalline 5-methoxy-n,n-diallyltryptamine compounds

CRYSTAL OF TRICYCLIC COMPOUND ACTING ON CRBN PROTEIN AND PREPARATION METHOD THEREFOR

NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME

Monohydrate Salt of Denatonium Acetate

THE SALTS OF A COMPOUND AND THE CRYSTALLINE FORMS THEREOF

Compositions for treatment of ocular diseases

SALTS AND CRYSTALLINE FORMS OF A TAAR1 AGONIST

Nitrile-Containing Antiviral Compounds

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

CRYSTAL FORM OF NITROXOLINE PRODRUG, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

ZIRCONIUM PHOSPHATE

METHYLATION OF MCL-1 COMPOUNDS

Solid state forms of Belumosudil and Belumosudil salts

Complexation of pirfenidone with polyphenolic calixarene or resorcin[4]arenes

PROCESSES OF MAKING 3-FLUORO-5-(((1S,2aR)-1,3,3,4,4-PENTAFLUORO-2a-HYDROXY-2,2a,3,4-TETRAHYDRO-1H-CYCLOPENTA[CD]INDEN-7-YL)OXY)-BENZONITRILE AND POLYMORPHS THEREOF

BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

CRYSTAL OF PDE3/PDE4 DUAL INHIBITOR AND USE THEREOF

CRYSTAL FORM OF AROMATIC VINYL DERIVATIVES, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Process for the preparation of iloprost

SYNTHETIC PROCESSES AND INTERMEDIATES

Phosphonium compound, reagent kit for derivatization, mass spectrometric method, and method for producing phosphonium compound

Crystalline norpsilocin compounds

Salts of a Pim kinase inhibitor

Isofagomine salts, methods of use and formulations

Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide

Salts and crystal forms of omecamtiv mecarbil

PROCESSES FOR THE PREPARATION OF GLASDEGIB AND SALT THEREOF AND SOLID STATE FORMS OF GLASDEGIB MALEATE AND PROCESS FOR PREPARATION THEREOF

(Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof

Crystalline salts of peptide epoxyketone immunoproteasome inhibitor

CRYSTALS OF ALKYNYL-CONTAINING COMPOUND, SALT AND SOLVATE THEREOF, PREPARATION METHOD, AND APPLICATIONS

METHODS OF TREATING PARKINSON'S DISEASE

CRYSTALLINE FORM OF FLUVATINIB OR FLUVATINIB METHANESULFONATE AND PREPARATION METHOD THEREFOR

5-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF MAKING, AND USE THEREOF

SALTS AND POLYMORPHIC FORMS OF 6-CHLORO-7-(4-(4-CHLOROBENZYL)PIPERAZIN-1-YL)-2-(1,3-DIMETHYL-1H-PYRAZOL-4-YL)-3H-IMIDAZO[4,5-B]PYRIDINE

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

METHODS AND PROCESSES FOR THE PREPARATION OF KDM1A INHIBITORS

Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof

SOLID STATE FORMS OF AVAPRITINIB AND PROCESS FOR PREPARATION THEREOF

Crystal form of pyrrolidinyl urea derivative and application thereof

EBNA1 inhibitor crystalline forms, and methods of preparing and using same

Method for producing allulose crystals

Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate

Substituted pyridines as DNMT1 inhibitors

Phenylcarbamate crystalline form and method for manufacturing the same

COMPOSITION AND METHOD FOR PRODUCING SAME

PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)

SSTR4 agonist salts

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor

Solid state forms of Mitapivat and process for preparation thereof

PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM

SOLID STATE FORMS OF ASCIMINIB AND PROCESSES FOR THE PREPARATION THEREOF

INTERMEDIATE USEFUL FOR SYNTHESIS OF SGLT INHIBITOR AND METHOD FOR PREPARING SGLT INHIBITOR USING SAME

HYDRATED CRYSTALLINE POLYNUCLEAR METAL COMPLEX, HYDRATED CRYSTALLINE POLYNUCLEAR METAL COMPLEX INCLUDING A GUEST COMPOUND ANALYTE AND ITS USE IN A METHOD FOR DETERMINING MOLECULAR STRUCTURE OF THE GUEST COMPOUND ANALYTE

Crystalline forms of ALDH2 modulators

Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulators

Morphic forms of danicopan

POLYMORPHS OF ELAFIBRANOR

COMPOUNDS AND THEIR USE FOR THE TREATMENT OF ALPHA1-ANTITRYPSIN DEFICIENCY

Crystal forms of 2-[4-[(2,3,4- trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate

SOLID FORMS OF TEZACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF

GEMFIBROZIL FORMULATION

Method for the synthesis of 2,4-dimethylpyrimidin-5-ol, intermediates, and method for the synthesis of Lemborexant using the intermediates

Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof

Crystalline forms of tenofovir alafenamide

CRYSTALLINE FORM OF JAK INHIBITOR AND APPLICATION THEREOF

Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide

Hydrate of dimethylaminomicheliolide fumarate and preparation method therefor and use thereof

Fasoracetam crystalline forms

Polymorphic Form of (-)-Cibenzoline Succinate

SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOF

Polymorphic forms of metopimazine

Crystalline epinephrine malonate salt

5-methoxy-N,N-dimethyltryptamine crystalline forms

Inhalable imatinib formulations, manufacture, and uses thereof

Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction

METHOD FOR IMPROVING THE HUE OF RECYCLED BIS(2-HYDROXYETHYL) TEREPHTHALATE

Bicyclic 1,4-diazepanones and therapeutic uses thereof

PROCESS OF SYNTHESIS OF NOVEL CHROMIUM (III) COMPLEXES OF SCHIFF BASE LIGANDS AND THEIR USE THERE OF AS THERAPEUTIC AGENTS

Compounds and their use

Polymorphisms of HM30181 mesylate

NOVEL SALTS OF NILOTINIB AND POLYMORPHIC FORMS THEREOF

CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE

Cycloalkane-1,3-diamine derivative

POLYMORPH OF EP4 RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF

Synthesis of antibacterial aminoglycoside analogs

Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide

Crystal forms and production methods thereof

SOLID STATE FORMS OF AVASOPASEM MANGANESE AND PROCESS FOR PREPARATION THEREOF

Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof

PROCESSES FOR PREPARING TUCATINIB POLYMORPHS

CO-CRYSTALS AND SALTS OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE

METHOD FOR PREPARING COUMARIN COMPOUNDS SUBSTITUTED BY AMIDOALKYL AT 3-POSITION, THE PRODUCTS AND RELATED INTERMEDIATES THEREOF

COMPOUNDS AND METHODS FOR THE DIAGNOSIS, IMAGING AND TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS

AMORPHOUS FORM OR CRYSTALLINE FORM OF 2-INDOLINOLINOLOLYLSPIRONONE COMPOUNDS OR THEIR SALTS, SOLVENT COMPLEXES

HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER

Citrate salt, pharmaceutical compositions, and methods of making and using the same

NOVEL METHOD FOR SYNTHESIZING DECURSIN DERIVATIVE

LARGE SCALE PROCESS

Crystalline forms of nicotinamide riboside chloride

Solid forms of 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl)ethyl]phenyl]ethyl]amino]-1-ethyl-4H-pyrimido[4,5-d][1,3]oxazin-2-one

IRAK4 INHIBITOR CRYSTAL AND PREPARATION METHOD THEREFOR

Crystal form of pyridopyrimidine derivative and preparation method thereof

SOLID STATE FORMS OF BLARCAMESINE SALTS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

CO-CRYSTALS OF TRAMADOL AND COXIBS

Solid State Form of Pyroxasulfone

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

SOLID STATE FORMS OF MAVACAMTEN AND PROCESS FOR PREPARATION THEREOF

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

Crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile

CRYSTALLINE AND LIQUID CRYSTALLINE 25-HYDROXY-CHOLEST-5-EN-3-SULFATE SODIUM AND METHODS FOR PREPARING SAME

MESYLATE SALT OF PARA-TOPOLIN, COMPOSITIONS CONTAINING SAID SALT AND USE THEREOF

BILE ACID DERIVATIVE SALT, CRYSTAL STRUCTURE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

Salt Forms of a Kinase Inhibitor

SALTS/COCRYSTALS OF (R)-N-(4-CHLOROPHENYL)-2-((1S,4S)-4-(6-FLUOROQUINOLIN-4-YL)CYCLOHEXYL)PROPANAMIDE

Preparation of Trifarotene and intermediates and polymorphs thereof

Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

METHODS OF TREATING DESMOID TUMORS WITH (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE

DEUCRAVACITINIB CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF

COCRYSTALS OF PTEROSTILBENE AND COMPOSITIONS COMPRISING THEM

Bicyclic compounds and their uses

MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE

SALT FORM AND CRYSTAL FORM OF MUTANT IDH1 INHIBITOR AND PREPARATION METHOD THEREFOR

Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine Salt

Morphic forms of G1T38 and methods of manufacture thereof

NEW CRYSTALLINE FORMS OF A SUCCINATE SALT OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE -6-CARBOXYLIC ACID DIMETHYLAMIDE

UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD THEREFOR AND USE THEREOF

METHOD FOR THE INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL) METHYL)PROPANOYL)-L-ALANINE

STEREOSELECTIVE PROCESS FOR PREPARING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES

BMS-986165 CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF

Solvents, methods, and systems for isolating botanical extracts from plants

CRYSTALLINE FORMS OF SODIUM SALT OF BEMPEDOIC ACID

Salts of R-ketorolac

[1,2,4]Triazolo[4,3-B]Pyridazines For Use in the Treatment of Proliferative Diseases

CRYSTALS AND PRODUCTION METHOD FOR THE SAME

Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof

Processes for converting cannabinoids into cannabinoid derivatives and recovering the same

Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same

Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING A SAGE1-RELATED CONDITION

Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine

CYCLOALKANE-1,3-DIAMINE DERIVATIVE

Crystalline forms and salt forms of a kinase inhibitor

Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)

CRYSTAL FORMS OF FUSED RING COMPOUND, AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Crystalline Form of a 7H-Benzo[7]Annulene-2-Carboxylic Acid Derivative

Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)

NOVEL SALTS OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS

METHOD FOR MANUFACTURING REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT, AND REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT

METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN FORMULATIONS

CRYSTAL FORM OF NUCLEOPROTEIN INHIBITOR AND USE THEREOF

PROCESS FOR THE CONTINUOUS MANUFACTURE OF STATINS

BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES

A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF

PROCESS FOR PREPARING CHROMAN COMPOUNDS

HDAC INHIBITOR SOLID STATE FORMS

PROCESS FOR PURIFICATION OF MALONIC ACID FROM FERMENTATION BROTH

AMLODIPINE MESYLATE MONOHYDRATE PREPARATION METHOD THEREFOR AND USE THEREOF

Crystalline forms of trofinetide

TREATMENT OF DEPRESSION AND OTHER VARIOUS DISORDERS WITH PSILOCYBIN

NOVEL CRYSTALLINE FORM OF GPR40 AGONIST

SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME

ADDITIVE USED IN METHIONINE PREPARATION PROCESS, AND METHIONINE PREPARATION METHOD

Crystals and production method for the same

Compound functioning as bromodomain protein inhibitor, and composition

Crystalline forms of (S, E)-4-(dimethylamino)-N-(3-(4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)but-2- enamide free base

Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same

ORGANIC ACID AND THERMAL TREATMENT OF PURIFIED 2,5-FURANDICARBOXYLIC ACID

CRYSTAL OF INDOCYANINE COMPOUND

Melanocortin 4 receptor antagonists and uses thereof

NOVEL PHTHALOCYANINE NANOWIRES AND USES THEREFOR

GABAA POSITIVE ALLOSTERIC MODULATOR COMPOUNDS, METHODS OF MAKING, AND USES THEREOF

Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof

NEW SOLID STATE FORM OF LURBINECTEDIN

THREE FUSED RING DERIVATIVE-CONTAINING SALT OR CRYSTAL FORM AND PHARMACEUTICAL COMPOSITION THEREOF

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

PROCESS FOR PRODUCING HERBICIDE AND INTERMEDIATE THEREOF

Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same

CRYSTALLINE FORM OF ACETYLCHOLINESTERASE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

CRYSTALLINE FORMS OF VAMOROLONE

CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL

Crystalline bortezomib process

AMORPHOUS FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF

LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES

WATER AND THERMAL TREATMENT OF PURIFIED 2,5-FURANDICARBOXYLIC ACID

CRYSTAL FORM OF QUINOLINONE COMPOUND AND USE THEREOF

POLYMORPHS OF PHENYL PYRROLE AMINOGUANDIUM SALTS

CO-CRYSTAL OF KETOPROFEN AND ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF

METHODS FOR TREATING ANXIETY DISORDERS, HEADACHE DISORDERS, AND EATING DISORDERS WITH PSILOCYBIN

Methods for producing cyclic compounds comprising N-substituted amino acid residues

POLYMORPHS OF A MACROCYCLIC KINASE INHIBITOR

Oxazole compound crystal

ACID ADDITION SALT OF RORy REGULATOR

Method for preparing nicotinamide mononucleotide cocrystal

SOLID STATE FORMS OF LUCERASTAT AND PROCESS FOR PREPARATION THEREOF

NOVEL SALT OF TERPHENYL COMPOUND

TREATMENT OF AUTOINFLAMMATORY DISORDERS

AMORPHOUS SOLID DISPERSION OF PYRAZOLE-AMIDE COMPOUND

NICOTINAMIDE MONONUCLEOTIDE-ISONICOTINE COCRYSTAL AND COMPOSITION THEREOF

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Crystal form of hepatitis B surface antigen inhibitor and application thereof

Salts, crystal forms, and production methods thereof

CRYSTALLINE FORM OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD OF PREPARATION, AND USE THEREOF

Crystal form of lanifibranor, preparation method therefor, and use thereof

CO-CRYSTAL AND/OR EUTECTIC CRYSTAL OF KOJIC ACID, COMPOSITIONS COMPRISING THE SAME, PROCESS OF PRODUCING THE SAME, AND USES THEREOF

Process for preparing pitolisant hydrochloride and solid-state forms thereof

CRYSTAL OF 3-(DIFLUOROMETHYL)-1-METHYL-N-(1,1,3-TRIMETHYL-2,3-DIHYDRO-1H-INDEN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE

SOLID FORMS OF OMECAMTIV MECARBIL DIHYDROCHLORIDE AND PROCESSES THEREOF

A Crystalline form of (R)-terbutaline Hydrochloride

Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use

CRYSTALLINE FORMS OF N-(4-(1-(2,6-DIFLUOROBENZYL)-5-((DIMETHYLAMINO)METHYL)-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-N'-METHOXYUREA

Pyrimidine compound as JAK kinase inhibitor

Crystal of 1,3,5-triazine derivative or solvate thereof and method for producing same

Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine

Method for Separating Water-Containing Crystals, Method for Producing Methacrylic Acid, and Method for Producing Methacrylic Acid Ester

METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION

COMPOSITIONS COMPRISING HMOS, THEIR PRODUCTION AND USE FOR THE PREVENTION AND/OR TREATMENT OF VIRAL AND/OR BACTERIAL INFECTIONS

TREATMENT OF ARTHRITIS

Polymorph form of (r)-2-[2-amino-3-(indol-3-yl)propionylamino]-2- methylpropionic acid and uses thereof

CRYSTALLINE FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF

SOLID FORMS OF PONATINIB HYDROCHLORIDE AND PROCESS THEREOF

NOVEL PURINE DERIVATIVE, INTERMEDIATE AND APPLICATION THEREOF IN PREPARING ANTICANCER MEDICINE

Crystalline form of Tolebrutinib

SALTS AND FORMS OF AN ESTROGEN RECEPTOR MODULATOR

CRYSTALLINE FORMS OF A BIPHENYL COMPOUND

Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates

Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts

NEW N,N-DIMETHYLTRYPTAMINE SALTS AND CRYSTALLINE SALT FORMS

Process for the preparation of a metastable crystal modification of n-(aminoiminomethyl)-2-aminoacetic acid (III)

Methods of making bempedoic acid and compositions of the same

TREATMENT OF CANCER USING A COMBINATION COMPRISING MULTI-TYROSINE KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR

FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE

Amorphous efinaconazole solid dispersion

Dominant salt forms of pyrimidine derivatives, and crystal forms thereof

Material for the treatment of gastro-intestinal disorders

AXL INHIBITOR FORMULATIONS

Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof

Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors

SOLID STATE FORMS OF ARRY-797 AND PROCESS FOR PREPARATION THEREOF

Crystalline forms of plasma kallikrein inhibitors

Crystalline salts of psilocin

SOLID STATE FORMS OF FEZAGEPRAS AND PROCESS FOR PREPARATION THEREOF

SOLID FORMS OF DIMETHOXYPILLAR[5]ARENE (DMP5): HYDROCARBON FUEL UPGRADING AND GAS SORPTION

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole